Zhaoting Li

Zhaoting Li

Auto-generated profile, based on publicly available information

Zhaoting Li

Department of Pharmaceutical Science, Division of Biomedical Health Sciences, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, 518172, PR China; Department of Biomedical Sciences, Division of Biomedical Health Sciences, The Chinese University of Hong Kong, Shenzhen, Guangdong, 518172, PR China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2022 in Science Advances
Verified
Journal Article
Open access
Jun LiuJun Liu
Jun Liu
Yixin WangYixin Wang
Yixin Wang
WHWilliam John Heelan
William John Heelan
YCYu Chen
Yu Chen
ZLZhaoting Li
Zhaoting Li
QHQuanyin Hu
Quanyin Hu
Inflammatory bowel diseases (IBDs) are often associated with elevated levels of reactive oxygen species (ROS) and highly dysregulated gut microbiota. In this study, we synthesized a polymer of hyaluronic acid–poly(propylene sulfide) (HA-PPS) and developed ROS-scavenging nanoparticles (HPN) that could effectively scavenge ROS. To achieve colon tissue targeting effects, the HPN nanoparticles were conjugated to the surface of modified probiotic Escherichia coli Nissle 1917 (EcN). To enhance the bacteriotherapy of EcN, we encapsulated EcN cells with a poly-norepinephrine (NE) layer that can protect EcN against environmental assaults to improve the viability of EcN in oral delivery and prolong the retention time of EcN in the intestine due to its strong mucoadhesive capability. In the dextran sulfate sodium–induced mouse colitis models, HPN-NE-EcN showed substantially enhanced prophylactic and therapeutic efficacy. Furthermore, the abundance and diversity of gut microbiota were increased after treatment with HPN-NE-EcN, contributing to the alleviation of IBDs.

4 August 2021 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
ZLZhaoting Li
Zhaoting Li
YWYixin Wang
Yixin Wang
Jun LiuJun Liu
Jun Liu
PRPiper Rawding
Piper Rawding
JBJiyoon Bu
Jiyoon Bu
QHQuanyin Hu
Quanyin Hu

6 April 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZLZhaoting Li
Zhaoting Li
YDYingyue Ding
Yingyue Ding
Jun LiuJun Liu
Jun Liu
JWJianxin Wang
Jianxin Wang
FMFanyi Mo
Fanyi Mo
QHQuanyin Hu
Quanyin Hu
Immunosuppressive cells residing in the tumor microenvironment, especially tumor associated macrophages (TAMs), hinder the infiltration and activation of T cells, limiting the anti-cancer outcomes of immune checkpoint blockade. Here, we report a biocompatible alginate-based hydrogel loaded with Pexidartinib (PLX)-encapsulated nanoparticles that gradually release PLX at the tumor site to block colony-stimulating factor 1 receptors (CSF1R) for depleting TAMs. The controlled TAM depletion creates a favorable milieu for facilitating local and systemic delivery of anti-programmed cell death protein 1 (aPD-1) antibody-conjugated platelets to inhibit post-surgery tumor recurrence. The tumor immunosuppressive microenvironment is also reprogrammed by TAM elimination, further promoting the infiltration of T cells into tumor tissues. Moreover, the inflammatory environment after surgery could trigger the activation of platelets to facilitate the release of aPD-1 accompanied with platelet-derived microparticles binding to PD-1 receptors for re-activating T cells. All these results collectively indicate that the immunotherapeutic efficacy against tumor recurrence of both local and systemic administration of aPD-1 antibody-conjugated platelets could be strengthened by local depletion of TAMs through the hydrogel reservoir.

15 May 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
ZLZhaoting Li
Zhaoting Li
Yixin WangYixin Wang
Yixin Wang
YSYuexin Shen
Yuexin Shen
CQChenggen Qian
Chenggen Qian
DODavid Oupicky
David Oupicky
MSMinjie Sun
Minjie Sun
CXCR4 antagonistic nanocomplex regulates the immune process to enhance anti–PD-L1 immunotherapy.

24 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZLZhaoting Li
Zhaoting Li
FMFanyi Mo
Fanyi Mo
YWYixin Wang
Yixin Wang
WLWen Li
Wen Li
YCYu Chen
Yu Chen
QHQuanyin Hu
Quanyin Hu
Pore-forming Gasdermin protein-induced pyroptosis in tumor cells promotes anti-tumor immune response through the release of pro-inflammatory cytokines and immunogenic substances after cell rupture. However, endosomal sorting complexes required for transport (ESCRT) III-mediated cell membrane repair significantly diminishes the tumor cell pyroptosis by repairing and subsequently removing gasdermin pores. Here, we show that blocking calcium influx-triggered ESCRT III-dependent membrane repair through a biodegradable nanoparticle-mediated sustained release of calcium chelator (EI-NP) strongly enhances the intracellularly delivered GSDMD-induced tumor pyroptosis via a bacteria-based delivery system (VNP-GD). An injectable hydrogel and a lyophilized hydrogel-based cell patch are developed for peritumoral administration for treating primary and metastatic tumors, and implantation for treating inoperable tumors respectively. The hydrogels, functioning as the local therapeutic reservoirs, can sustainedly release VNP-GD to effectively trigger tumor pyroptosis and EI-NP to prevent the ESCRT III-induced plasma membrane repair to boost the pyroptosis effects, working synergistically to augment the anti-tumor immune response.

25 March 2021 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
ZLZhaoting Li
Zhaoting Li
Yixin WangYixin Wang
Yixin Wang
YDYingyue Ding
Yingyue Ding
LRLauren Repp
Lauren Repp
GKGlen S. Kwon
Glen S. Kwon
QHQuanyin Hu
Quanyin Hu